Inovative Renal Care (IRC), have completed the previously announced transaction to acquire American Renal Associates Holdings, Inc., effective January 25, 2021. Immediately prior to the Effective Time, in connection with the consummation of the Merger and in accordance with the Merger Agreement, each member of ARA’s board of directors (the “ Board”) resigned from and ceased serving on the Board and any and all committees thereof. No director resigned as a result of any disagreement with ARA on any matter relating to ARA’s operations, policies or practices. The members of the Board immediately prior to the Effective Time were Joseph A. Carlucci, Syed T. Kamal, Michael E. Boxer, Susanne V. Clark, Thomas W. Erickson, Robert H. Fish, Jeremy W. Gelber, Jared S. Hendricks, Christopher J. Hocevar and John M. Jureller. Immediately following the Effective Time, Scott Hilinski resigned as the President of ARA and Syed T. Kamal was appointed as the President of ARA.